Welcome to our dedicated page for Clarivate Plc news (Ticker: CLVT), a resource for investors and traders seeking the latest updates and insights on Clarivate Plc stock.
Clarivate Plc (NYSE: CLVT) is described as a leading global provider of transformative intelligence, with news that reflects its activities across Academia & Government, Intellectual Property and Life Sciences & Healthcare. Company announcements frequently highlight new AI-powered tools, analytical reports and customer adoptions that illustrate how Clarivate combines enriched data, analytics and workflow software.
Recent news includes the launch of the Web of Science Research Assistant, a generative AI-powered tool that helps researchers conduct natural-language searches, perform literature reviews and explore visualizations based on more than 120 years of publication and citation data. Clarivate also reports on studies such as the Pulse of the Library report, which surveys thousands of librarians worldwide about AI adoption, open science and budget pressures, and on the annual Highly Cited Researchers list, which recognizes researchers whose work has had broad influence based on Web of Science data.
In Intellectual Property, Clarivate issues updates on solutions like IPfolio and Derwent Patent Monitor, including customer selections by organizations such as Nissan Motor Co., Ltd. and FUJIFILM Holdings Corporation. These stories emphasize how IP management platforms and AI-enabled patent review tools support more efficient IP operations and collaboration between IP and R&D teams.
Life sciences and healthcare news often centers on Clarivate analyses such as the Drugs to Watch report and Companies to Watch reports, which identify emerging therapies and innovative companies using integrated, AI-enhanced datasets. Visitors to this news page can follow Clarivate’s product launches, research reports, customer case studies and investor-related announcements to understand how the company is applying data and AI across its core markets.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Clarivate Plc (NYSE:CLVT) released a report highlighting the impact of globalization on U.S. research, urging for continued investment and collaboration to sustain its position as a science leader. The analysis, drawn from the Institute for Scientific Information, points out that U.S. research growth has not kept pace with global counterparts, particularly in Asia and the EU. Key findings include a doubling of international collaboration, particularly with Mainland China, and a decline in the diversity of research subjects due to faster budget increases in biomedicine. Furthermore, research output is unevenly distributed across the U.S., necessitating focused funding in weaker areas. The report warns that the U.S. no longer dominates global research, with other nations producing increasingly impactful papers.
On April 26, 2023, Clarivate (NYSE: CLVT) announced the appointment of Henry Levy as President of its Life Sciences & Healthcare segment, effective May 1, 2023. Levy, formerly with Veeva Systems, possesses over 25 years of experience in the life sciences sector, having held prestigious roles focused on enhancing drug development and commercialization. CEO Jonathan Gear expressed confidence in Levy's ability to accelerate growth and innovation within the segment, which aims to connect clients with transformative intelligence and data technology. This appointment rounds out recent leadership changes, including Gordon Samson and Bar Veinstein as Presidents of Intellectual Property and Academia & Government, respectively.
Clarivate Plc (NYSE: CLVT) announced it will report its financial results for Q1 2023 on May 9, 2023, before the market opens. The earnings release and supplemental information will be available on the Clarivate investor website. A conference call and webcast to discuss the results will occur on the same day at 9:00 AM Eastern Time. Interested participants can access the live broadcast through the investor relations section or by dialing the provided numbers. This event reflects Clarivate's commitment to transparency in sharing vital business information.
For more details, including the conference call access numbers and links to the live webcast, please visit the company's investor relations page.